The UAE has become the second country worldwide to approve Itvisma, a groundbreaking gene therapy for spinal muscular atrophy ...
The Times of Israel on MSN
In surprising breakthrough, scientists in Israel find cancer may help heal the failing heart
A study by researchers at the Technion finds that injecting cancerous serum in mice decreased cardiac fibrosis, paving the ...
Quebec, Canada, December 20th, 2025, FinanceWireInternational clinician and integrative health researcher Oxana Ali has ...
Determining which patients should receive the treatment will still require individual risk-benefit assessments, experts say.
Dubai, UAE: The Emirates Drug Establishment (EDE) has announced the approval of Itvisma™ (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular ...
AZ Animals on MSN
Do slugs have teeth? Inside one of nature’s weirdest mouths
Have you ever wondered if slugs can smile — or if they even have teeth? Their smooth bodies and simple appearance might ...
Edex Live on MSN
UAE approves gene replacement therapy for wider SMA age group
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular atrophy (SMA) ...
The "agile, powerful, lightweight," motorcycle has been "engineered to break limits," the architectural firm told Newsweek.
Dec 16 (Reuters) - U.S. Health Secretary Robert F. Kennedy Jr. on Tuesday added two rare genetic disorders, Duchenne ...
Emirates News Agency on MSN
UAE approves gene replacement therapy for new age group in spinal muscular atrophy patients
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that ...
Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback